Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase Ib Trial of Atezolizumab and BCG in High Risk BCG naïve Non-muscle Invasive Bladder Cancer (NMIBC) Patients: BladderGATE Study

NCT04134000 is registered in ClinicalTrials.gov with Fundacion Oncosur as lead sponsor.

NCT NCT04134000
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04134000 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase Ib Trial of Atezolizumab and BCG in High Risk BCG naïve Non-muscle Invasive Bladder Cancer (NMIBC) Patients: BladderGATE Study
Lead sponsor
Fundacion Oncosur
Phase
Phase 1
Overall status
Unknown status
Start date
February 3, 2020
Completion date
September 30, 2024
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

invasive bladder cancer